• Successful completion of $350 million institutional placement
• Placement priced at $16.70 per share, representing a 5.3% discount
• Proceeds to fund organic investment in laboratory network and support future growth

ALS Limited (ASX: ALQ) has announced the successful completion of its fully underwritten $350 million institutional placement (Placement) of approximately 21.0 million new fully paid ordinary shares (New Shares), equivalent to approximately 4.3% of existing ordinary shares on issue. The Placement was well supported and completed at a price of $16.70 per New Share, representing a 5.3% discount to the last closing Share price on 26 May 2025 of $17.64 and a 5.7% discount to the 5-day volume weighted average price of ALS shares (up to and including 26 May 2025) of A$17.71. The proceeds from the Placement will be used to fund organic investment in the laboratory network, with excess funds raised used to maintain balance sheet flexibility, support future growth initiatives and fund transaction costs. ALS is also undertaking a non-underwritten share purchase plan (SPP) targeting to raise up to $40 million, allowing eligible shareholders to acquire up to $30,000 in Shares without incurring brokerage, commission or other transaction costs. The SPP will be conducted at an issue price that is the lower of $16.70 (the same price as the Placement) or a 2.0% discount to the 5-day VWAP of ALS' Shares at the close of the SPP offer period.